---
title: >-
  WHO criticized a US-funded newborn vaccine trial as 'unethical', involving a
  $1.6 million CDC-awarded study of hepatitis B birth dose vaccine in
  Guinea-Bissau
slug: who-criticized-us-funded-hepatitis-b-vaccine-trial-guinea-bissau-unethical
topic: health
status: unresolved
summary: >-
  A clinical trial examining hepatitis B vaccine timing in newborns in
  Guinea-Bissau received CDC funding and faced WHO criticism regarding ethical
  concerns. The specific details of WHO's characterization, the exact funding
  amount, and the nature of the ethical concerns require verification from
  primary sources.
created: '2026-02-15'
updated: '2026-02-15'
sources:
  - title: Ars Technica report on WHO criticism
    url: ''
    type: news
    summary: News report indicating WHO criticism of US-funded vaccine trial
    needsResolution: true
  - title: CDC grant database or NIH Reporter
    url: 'https://reporter.nih.gov/ [VERIFY specific grant]'
    type: official
    summary: >-
      Federal database that would contain grant funding information for
      CDC-awarded studies
  - title: WHO statement on vaccine trial ethics
    url: ''
    type: official
    summary: Official WHO statement or report on ethical concerns regarding the trial
    needsResolution: true
  - title: ClinicalTrials.gov registry
    url: 'https://clinicaltrials.gov/ [VERIFY specific trial]'
    type: official
    summary: >-
      Federal registry where clinical trials conducted with US funding are
      typically registered
evidenceFor:
  - >-
    CDC has funded vaccine research in Guinea-Bissau through various mechanisms
    [requires specific grant verification]
  - >-
    Hepatitis B birth dose vaccine timing studies have been conducted in
    multiple countries including West African nations [requires specific study
    verification]
  - >-
    WHO has issued guidelines and ethical reviews of vaccine trials in
    developing nations [requires specific criticism verification]
evidenceAgainst:
  - >-
    The specific characterization of WHO's criticism as describing the trial as
    'unethical' requires verification from primary WHO documents
  - >-
    The exact funding amount of $1.6 million requires verification from CDC
    grant records or official announcements
  - >-
    The connection between all elements (WHO criticism, CDC funding amount,
    specific trial, and location) in a single study requires confirmation
timeline:
  - date: Unknown
    description: >-
      CDC reportedly awarded funding for hepatitis B vaccine trial in
      Guinea-Bissau
  - date: Unknown
    description: Clinical trial initiated examining hepatitis B birth dose vaccine timing
  - date: Unknown
    description: WHO reportedly issued criticism of trial on ethical grounds
  - date: Unknown
    description: Ars Technica published report on WHO criticism
whatThisMeans:
  - >-
    Clinical trials in low-income countries involving vaccines require oversight
    from multiple entities including local ethics committees, WHO, and funding
    agencies
  - >-
    The timing of hepatitis B vaccination at birth versus delayed administration
    is a subject of ongoing research to determine optimal health outcomes
  - >-
    Ethical concerns in international vaccine trials typically involve issues of
    informed consent, standard of care, post-trial access, and appropriateness
    of control groups
  - >-
    CDC funding of international vaccine research is part of global health
    initiatives, with grants subject to ethical review processes
sourcesVerified: false
relatedSlugs:
  - florida-university-measles-outbreak-21-states-2026
  - trump-cdc-grants-cut-blue-states-restraining-order
---

